87 related articles for article (PubMed ID: 27637923)
21. Array-based in situ fluorescence assay for profiling multiplex matrix metalloproteinases activities in tissue section.
Lei Z; Jian M; Wei J; Wang Y; Meng X; Wang Z
Anal Chim Acta; 2019 Oct; 1078():112-118. PubMed ID: 31358208
[TBL] [Abstract][Full Text] [Related]
22. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes.
Lee HD; Koo BH; Kim YH; Jeon OH; Kim DS
FASEB J; 2012 Jul; 26(7):3084-95. PubMed ID: 22505472
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays.
Maretzky T; Swendeman S; Mogollon E; Weskamp G; Sahin U; Reiss K; Blobel CP
Biochem J; 2017 Apr; 474(9):1467-1479. PubMed ID: 28264989
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.
Fedak PW; Moravec CS; McCarthy PM; Altamentova SM; Wong AP; Skrtic M; Verma S; Weisel RD; Li RK
Circulation; 2006 Jan; 113(2):238-45. PubMed ID: 16401770
[TBL] [Abstract][Full Text] [Related]
25. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J
Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence detection of MMP-9. II. Ratiometric FRET-based sensing with dually labeled specific peptide.
Fudala R; Rich R; Mukerjee A; Ranjan AP; Vishwanatha JK; Kurdowska AK; Gryczynski Z; Borejdo J; Gryczynski I
Curr Pharm Biotechnol; 2014; 14(13):1134-8. PubMed ID: 22339171
[TBL] [Abstract][Full Text] [Related]
27. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA
Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561
[TBL] [Abstract][Full Text] [Related]
28. Catalytic properties of ADAM12 and its domain deletion mutants.
Jacobsen J; Visse R; Sørensen HP; Enghild JJ; Brew K; Wewer UM; Nagase H
Biochemistry; 2008 Jan; 47(2):537-47. PubMed ID: 18081311
[TBL] [Abstract][Full Text] [Related]
29. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
30. Detection of ADAM15 in urine from patients with bladder cancer.
Gruba N; Musielak M; Rejmak W; Lesner A
Anal Biochem; 2022 Oct; 654():114805. PubMed ID: 35810783
[TBL] [Abstract][Full Text] [Related]
31. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.
Lorenzatti Hiles G; Bucheit A; Rubin JR; Hayward A; Cates AL; Day KC; El-Sawy L; Kunju LP; Daignault S; Lee CT; Liebert M; Hussain M; Day ML
PLoS One; 2016; 11(3):e0150138. PubMed ID: 26930657
[TBL] [Abstract][Full Text] [Related]
32. FRET study in oligopeptide-linked donor-acceptor system in PVA matrix.
Shah S; Mandecki W; Li J; Gryczynski Z; Borejdo J; Gryczynski I; Fudala R
Methods Appl Fluoresc; 2016 Dec; 4(4):047002. PubMed ID: 28192309
[TBL] [Abstract][Full Text] [Related]
33. Quantitative Proteomics Reveals That ADAM15 Can Have Proteolytic-Independent Functions in the Steady State.
Yang CY; Bonelli S; Calligaris M; Carreca AP; Müller SA; Lichtenthaler SF; Troeberg L; Scilabra SD
Membranes (Basel); 2022 May; 12(6):. PubMed ID: 35736286
[TBL] [Abstract][Full Text] [Related]
34. Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease.
Konstantinidis AK; Richardson PL; Kurtz KA; Tripathi R; Chen CM; Huang P; Randolph J; Towne D; Donnelly J; Warrior U; Middleton T; Kati WM
Anal Biochem; 2007 Sep; 368(2):156-67. PubMed ID: 17644059
[TBL] [Abstract][Full Text] [Related]
35. ADAM15 adds to apoptosis resistance of synovial fibroblasts by modulating focal adhesion kinase signaling.
Böhm BB; Freund I; Krause K; Kinne RW; Burkhardt H
Arthritis Rheum; 2013 Nov; 65(11):2826-34. PubMed ID: 23918525
[TBL] [Abstract][Full Text] [Related]
36. The synthesis and application of Fmoc-Lys(5-Fam) building blocks.
Tokmina-Roszyk M; Tokmina-Roszyk D; Fields GB
Biopolymers; 2013 Jul; 100(4):347-55. PubMed ID: 23444261
[TBL] [Abstract][Full Text] [Related]
37. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
Gomes RA; Juliano L; Chagas JR; Hial V
Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
[TBL] [Abstract][Full Text] [Related]
38. The ADAM15 ectodomain is shed from secretory exosomes.
Lee HD; Kim YH; Koo BH; Kim DS
BMB Rep; 2015 May; 48(5):277-82. PubMed ID: 25208722
[TBL] [Abstract][Full Text] [Related]
39. Using fluorogenic peptide substrates to assay matrix metalloproteinases.
Fields GB
Methods Mol Biol; 2010; 622():393-433. PubMed ID: 20135296
[TBL] [Abstract][Full Text] [Related]
40. A high throughput fluorogenic substrate for stromelysin (MMP-3).
Bickett DM; Green MD; Wagner C; Roth JT; Berman J; McGeehan GM
Ann N Y Acad Sci; 1994 Sep; 732():351-5. PubMed ID: 7978805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
